Short answer
ORASURE TECHNOLOGIES INC (OSUR) filed an 8-K current report with the SEC on April 17, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Activist Altai withdraws prior nominations and stockholder proposal, reducing near-term proxy contest risk.
ORASURE TECHNOLOGIES INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Activist Altai withdraws prior nominations and stockholder proposal, reducing near-term proxy contest risk
- John D. Bertrand appointed Class II director and added to the Nominating and Corporate Governance Committee
- OraSure will nominate and support Bertrand at the 2026 annual meeting
- Company will seek stockholder approval to declassify the Board, enabling phased annual director elections
- Altai voting support and standstill protections run through March 31, 2027 or the 2027 nomination deadline
Item 5.02 · Departure/Election of Directors or Officers
- John D. Bertrand appointed independent Class II director effective April 16, 2026
- Board seat term runs through the 2026 Annual Meeting
- Nominating and Corporate Governance Committee assignment adds governance oversight
- $100,000 time-vested restricted-stock award, vesting after two years
- Appointment follows a Cooperation Agreement, indicating potential shareholder-engagement implications
Item 7.01 · Regulation FD Disclosure
- Exhibit 99.1 furnished under Regulation FD, but its substantive disclosure content is not included here
- Information not deemed “filed” under Exchange Act Section 18, limiting related liability exposure
- Exhibit not incorporated into other Securities Act or Exchange Act filings unless expressly referenced
Item EX-99.1 · Exhibit EX-99.1
- Appointment of John D. Bertrand adds independent director expertise in AI-enabled diagnostics and commercial healthcare technology
- Cooperation agreement ends Altai Capital’s director contest, reducing near-term proxy-fight risk
- Altai receives regular access to OraSure’s board and management for financial and strategic discussions
- Shareholders will vote on board declassification at the 2026 annual meeting, potentially increasing director accountability
- Standstill and voting provisions will be filed separately on Form 8-K, defining ongoing activist-investor constraints
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ORASURE TECHNOLOGIES INC 8-K filings
Get the next OSUR 8-K as it lands
Follow OSUR for push alerts, or ask the research agent what this filing means.